Supreme Court Rejects Plea Alleging Side Effects Of COVID-19 Vaccines

New Delhi:  The Supreme Court of India on Monday dismissed a petition alleging that COVID-19 vaccines caused severe side effects, including blood clotting, calling the plea as an attempt to create unnecessary alarm.

A bench led by Chief Justice DY Chandrachud, along with Justices JB Pardiwala and Manoj Misra, declined to entertain the petition, stating that it lacked merit. “We don’t want to rake this up. This is just to create a sensation,” remarked the bench, questioning the usefulness of the petition.

The court further highlighted the broader implications, suggesting that public health efforts might have been compromised if people had refrained from taking the vaccine.

During the proceedings, the court directly questioned the petitioner’s lawyer on whether he had taken the vaccine. After confirming that he had received the vaccine and experienced no side effects, the bench emphasized the lack of merit in the case.

The petition was filed by Priya Mishra and others, who sought to challenge the alleged adverse effects of the COVID-19 vaccination drive.

Case Details: PRIYA MISHRA AND ANR. vs UNION OF INDIA AND ORS., Diary No. 22945-2024

Related Posts

Fujifilm India launches therapeutic endoscopy portfolio at Endocon 2026

Fujifilm India, a leading healthcare technology company, has expanded its ELUXEO 8000 endoscopy portfolio with the launch of its next-generation therapeutic gastroscopes at Endocon 2026. India is witnessing a growing…

Draft bill proposes powers for DIs to inspect online pharmacy office premises

Amidst years of uncertainty over the regulation of e-pharmacies in the country, the draft Drugs, Medical Devices and Cosmetics Bill, 2026, proposes to bestow the powers with the drugs inspectors…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Fujifilm India launches therapeutic endoscopy portfolio at Endocon 2026

Fujifilm India launches therapeutic endoscopy portfolio at Endocon 2026

Draft bill proposes powers for DIs to inspect online pharmacy office premises

Draft bill proposes powers for DIs to inspect online pharmacy office premises

Argentina committed to reducing barriers to facilitate entry of Indian pharma sector: Government

Argentina committed to reducing barriers to facilitate entry of Indian pharma sector: Government

FDA cancels drug sale licences of Cipla Pharma & Life Sciences’ Pune Carry and Forwarding unit

FDA cancels drug sale licences of Cipla Pharma & Life Sciences’ Pune Carry and Forwarding unit

Delhi DCA mandates digital tracking for controlled substances on new DMS portal

Delhi DCA mandates digital tracking for controlled substances on new DMS portal

How much of Healthcare Research reaches Bedside in India? Or gets Lost in Translation?

How much of Healthcare Research reaches Bedside in India? Or gets Lost in Translation?